Vaccine Preventable Respiratory Disease in New Zealand
Publication Date
2017
Lead Organisation
TBC
Lead Researcher
Priya Veerasingam
Access Type
Internal
Primary Classification
Health and Wellbeing

New Zealand experiences a large disease burden from respiratory tract infections. Hospitalisation at < 2 years of age with pneumonia and bronchiolitis leads to persistence of respiratory symptoms 1 year later in at least one-third of children. Bronchiectasis, which results from recurrent childhood respiratory infections, remains a significant causes of premature death in New Zealand. The potential for this to be prevented by timely immunisation has not been studied. The study will determine the timeliness and completeness of preschool immunisation in NZ, describe recurrent and chronic respiratory disease up to 5 years of age and whether delayed or incomplete immunisations increase the risk of recurrent and chronic respiratory disease.